Yuichi Iwaki
Fundador en MEDICINOVA, INC. .
Fortuna: 1 M $ al 30/04/2024
Cargos activos de Yuichi Iwaki
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MEDICINOVA, INC. | Director/Miembro de la Junta | 01/03/2007 | - |
| Director Ejecutivo | 01/08/2005 | - | |
| Fundador | 26/09/2000 | - | |
| Presidente | 01/03/2006 | - | |
| Presidente | 26/09/2000 | 01/03/2007 | |
| Director Financiero/CFO | 22/04/2020 | 19/06/2020 | |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Director Ejecutivo | 18/12/2009 | - |
| Director/Miembro de la Junta | 01/11/1994 | 18/12/2009 | |
| University of South Carolina School of Medicine | Corporate Officer/Principal | 01/01/1992 | - |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - | - |
Historial de carrera de Yuichi Iwaki
Antiguos cargos conocidos de Yuichi Iwaki.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Pittsburgh School of Medicine | Corporate Officer/Principal | 01/01/1989 | 01/01/1991 |
Antyra, Inc.
 Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | Director/Miembro de la Junta | - | - |
| AMCOL INTERNATIONAL CORPORATION | Presidente | - | - |
| Presidente | - | - |
Formación de Yuichi Iwaki.
| Sapporo Medical University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Japón | 2 |
Operativa
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Sectorial
| Consumer Services | 5 |
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MEDICINOVA, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
AMCOL International Corp.
 AMCOL International Corp. Construction MaterialsNon-Energy Minerals AMCOL International Corp. produces value-added, specialty minerals, and related product. The company was founded on December 30, 1959 and is headquartered in Hoffman Estates, IL. | Non-Energy Minerals |
Antyra, Inc.
Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Yuichi Iwaki
- Experiencia
